In This Article:
In the last week, the United States market has stayed flat, yet it is up 7.8% over the past year with earnings forecasted to grow by 14% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these positive market trends.
Top 10 High Growth Tech Companies In The United States
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Super Micro Computer | 20.44% | 29.79% | ★★★★★★ |
TG Therapeutics | 26.18% | 37.61% | ★★★★★★ |
Alkami Technology | 20.52% | 85.16% | ★★★★★★ |
Travere Therapeutics | 28.43% | 65.01% | ★★★★★★ |
AVITA Medical | 27.91% | 55.77% | ★★★★★★ |
Clene | 60.86% | 63.07% | ★★★★★★ |
Alnylam Pharmaceuticals | 22.76% | 58.40% | ★★★★★★ |
TKO Group Holdings | 22.48% | 25.17% | ★★★★★★ |
Lumentum Holdings | 21.55% | 119.67% | ★★★★★★ |
Ascendis Pharma | 32.36% | 59.79% | ★★★★★★ |
Click here to see the full list of 233 stocks from our US High Growth Tech and AI Stocks screener.
Let's uncover some gems from our specialized screener.
Exact Sciences
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Exact Sciences Corporation is a company that specializes in providing cancer screening and diagnostic test products both in the United States and internationally, with a market capitalization of approximately $8.34 billion.
Operations: The company generates revenue primarily from its biotechnology segment, which accounted for approximately $2.76 billion.
Exact Sciences, a key figure in precision oncology, has demonstrated robust growth with a 9.5% annual increase in revenue and an impressive 85.1% projected annual earnings growth. The company's strategic focus on R&D is evident from its substantial investment, aligning with recent innovations like the Oncotype DX Breast Recurrence Score® test, which has enhanced patient outcomes and streamlined treatment processes. These advancements not only solidify its market position but also promise to shape future industry standards, underpinning potential long-term growth in a competitive landscape.
-
Unlock comprehensive insights into our analysis of Exact Sciences stock in this health report.
-
Evaluate Exact Sciences' historical performance by accessing our past performance report.
Intuit
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Intuit Inc. is a company that offers financial management, compliance, and marketing products and services primarily in the United States, with a market capitalization of approximately $171.89 billion.
Operations: Intuit Inc. generates revenue through diverse segments, including Pro-Tax ($594 million), Consumer ($4.45 billion), Credit Karma ($1.96 billion), and Global Business Solutions ($10.16 billion). The company's operations focus on providing a range of financial management and compliance services in the U.S., leveraging its significant market presence to cater to various customer needs across these segments.